Literature DB >> 25556602

The diagnosis of chronic obstructive pulmonary disease.

Rainer Burkhardt1, Wulf Pankow.   

Abstract

BACKGROUND: Estimates of the prevalence of chronic obstructive pulmonary disease (COPD) in Germany range from 1.9% to 13.2%, depending on the population studied and the investigative methods used. About 30% of all patients already have severe airway obstruction by the time the condition is diagnosed.
METHODS: Review of pertinent literature retrieved by a selective search, including current guidelines and textbooks.
RESULTS: Smoking is the main risk factor for COPD. The diagnosis is based on characteristic symptoms that patients at risk should be actively asked about-cough, dyspnea, diminished physical reserve, and frequent airway infections-together with abnormal pulmonary function tests. Spirometry usually suffices to document impaired air flow. The clinical evaluation and the treatment strategy are based on the severity of airway obstruction and dyspnea, and the frequency of exacerbations. According to a European study, dyspnea is present in 73% of persons with severe COPD, expectoration in 64%, cough in 59%, and wheezing in 42%. Asthma, congestive heart failure, and interstitial lung disease are the main differential diagnoses.
CONCLUSION: COPD may begin with symptoms that are only mild at first even in a longstanding smoker. The available diagnostic techniques need better prospective validation with respect to relevant endpoints, including mortality, symptom progression, quality of life, and frequency of exacerbations.

Entities:  

Mesh:

Year:  2014        PMID: 25556602      PMCID: PMC4284520          DOI: 10.3238/arztebl.2014.0834

Source DB:  PubMed          Journal:  Dtsch Arztebl Int        ISSN: 1866-0452            Impact factor:   5.594


  57 in total

1.  Is my lung function really that good? Flow-type spirometer problems that elevate test results.

Authors:  Mary C Townsend; John L Hankinson; Larry A Lindesmith; William A Slivka; Gregg Stiver; Gerald T Ayres
Journal:  Chest       Date:  2004-05       Impact factor: 9.410

2.  Standardisation of spirometry.

Authors:  M R Miller; J Hankinson; V Brusasco; F Burgos; R Casaburi; A Coates; R Crapo; P Enright; C P M van der Grinten; P Gustafsson; R Jensen; D C Johnson; N MacIntyre; R McKay; D Navajas; O F Pedersen; R Pellegrino; G Viegi; J Wanger
Journal:  Eur Respir J       Date:  2005-08       Impact factor: 16.671

3.  Canadian Cohort Obstructive Lung Disease (CanCOLD): Fulfilling the need for longitudinal observational studies in COPD.

Authors:  Jean Bourbeau; Wan C Tan; Andrea Benedetti; Shawn D Aaron; Kenneth R Chapman; Harvey O Coxson; Robert Cowie; Mark Fitzgerald; Roger Goldstein; Paul Hernandez; Jonathon Leipsic; Francois Maltais; Darcy Marciniuk; Denis O'Donnell; Don D Sin
Journal:  COPD       Date:  2012-03-20       Impact factor: 2.409

4.  Does the clinical examination predict airflow limitation?

Authors:  D R Holleman; D L Simel
Journal:  JAMA       Date:  1995-01-25       Impact factor: 56.272

5.  Mild and moderate-to-severe COPD in nonsmokers: distinct demographic profiles.

Authors:  Carolyn E Behrendt
Journal:  Chest       Date:  2005-09       Impact factor: 9.410

Review 6.  Chronic obstructive pulmonary disease: definition and epidemiology.

Authors:  David M Mannino
Journal:  Respir Care       Date:  2003-12       Impact factor: 2.258

7.  The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease.

Authors:  Bartolome R Celli; Claudia G Cote; Jose M Marin; Ciro Casanova; Maria Montes de Oca; Reina A Mendez; Victor Pinto Plata; Howard J Cabral
Journal:  N Engl J Med       Date:  2004-03-04       Impact factor: 91.245

8.  The nature of small-airway obstruction in chronic obstructive pulmonary disease.

Authors:  James C Hogg; Fanny Chu; Soraya Utokaparch; Ryan Woods; W Mark Elliott; Liliana Buzatu; Ruben M Cherniack; Robert M Rogers; Frank C Sciurba; Harvey O Coxson; Peter D Paré
Journal:  N Engl J Med       Date:  2004-06-24       Impact factor: 91.245

Review 9.  Radiological diagnosis in lung disease: factoring treatment options into the choice of diagnostic modality.

Authors:  Mark O Wielpütz; Claus P Heußel; Felix J F Herth; Hans-Ulrich Kauczor
Journal:  Dtsch Arztebl Int       Date:  2014-03-14       Impact factor: 5.594

10.  COPD in never smokers: results from the population-based burden of obstructive lung disease study.

Authors:  Bernd Lamprecht; Mary Ann McBurnie; William M Vollmer; Gunnar Gudmundsson; Tobias Welte; Ewa Nizankowska-Mogilnicka; Michael Studnicka; Eric Bateman; Josep M Anto; Peter Burney; David M Mannino; Sonia A Buist
Journal:  Chest       Date:  2010-09-30       Impact factor: 9.410

View more
  12 in total

1.  In reply.

Authors:  Wulf Pankow; Rainer Burkhardt
Journal:  Dtsch Arztebl Int       Date:  2015-08-17       Impact factor: 5.594

2.  The preserve of primary care physicians.

Authors:  Thomas Hausen
Journal:  Dtsch Arztebl Int       Date:  2015-08-17       Impact factor: 5.594

3.  Diagnosis is difficult.

Authors:  Gerhard W Sybrecht
Journal:  Dtsch Arztebl Int       Date:  2015-08-17       Impact factor: 5.594

4.  Occupational preventive measures.

Authors:  Stefanie Seele; M Spallek
Journal:  Dtsch Arztebl Int       Date:  2015-08-17       Impact factor: 5.594

5.  Whole-Body Plethysmography in Suspected Asthma: A Prospective Study of Its Added Diagnostic Value in 302 Patients.

Authors:  Antonius Schneider; Johannes Schwarzbach; Bernhard Faderl; Hubert Hautmann; Rudolf A Jörres
Journal:  Dtsch Arztebl Int       Date:  2015-06-12       Impact factor: 5.594

6.  Chronic obstructive pulmonary disease- a growing cause of death and disability worldwide.

Authors:  Tobias Welte
Journal:  Dtsch Arztebl Int       Date:  2014-12-05       Impact factor: 5.594

Review 7.  The Differential Diagnosis of Dyspnea.

Authors:  Dominik Berliner; Nils Schneider; Tobias Welte; Johann Bauersachs
Journal:  Dtsch Arztebl Int       Date:  2016-12-09       Impact factor: 5.594

Review 8.  The Impact of ACE and ACE2 Gene Polymorphisms in Pulmonary Diseases Including COVID-19.

Authors:  Iphigenia Gintoni; Maria Adamopoulou; Christos Yapijakis
Journal:  In Vivo       Date:  2022 Jan-Feb       Impact factor: 2.155

Review 9.  [Somatic morbidity in the mentally ill].

Authors:  W Hewer; F Schneider
Journal:  Nervenarzt       Date:  2016-07       Impact factor: 1.214

Review 10.  Dynamics of airway response in lung microsections: a tool for studying airway-extra cellular matrix interactions.

Authors:  Mohammad Afzal Khan
Journal:  J Biomed Sci       Date:  2016-05-12       Impact factor: 8.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.